The 5th edition of the WHO Classification of Tumours of the Central Nervous System
introduces new entities, and provides updated guidance regarding the diagnostic criteria for …

Hemangioblastoma is a rare benign tumor that can affect the central nervous system
sporadically or in association with von Hippel-Lindau (VHL) syndrome. Despite the …

Objective The classification of brain tumors is a rapidly evolving field that requires extensive
integration of molecular diagnostic findings from an expanding set of platforms and assays …

Hemangioblastomas (HBs) are highly vascularized, slow-growing, rare benigntumors (WHO
grade I). They account for about 2% of intracranialneoplasms; however, they are the most …

Background: Neuroimaging has evolved from anatomical imaging toward a multi-modality
comprehensive anatomical and functional imaging in the past decades, important functional …

OBJECTIVE Hemangioblastomas are a frequent underlying cause of neurological morbidity
and death in patients with von Hippel–Lindau disease (VHL). Although these benign tumors …

Background The perioperative risk of sporadic hemangioblastomas (HBs) and von Hippel-
Lindau disease (VHL)–associated hemangioblastomas (VHL-associated HBs) remains …

Simple Summary Central Nervous System (CNS) hemangioblastomas (HBs) are rare and
benign tumors that may be sporadic or hereditary, linked mainly to von Hippel–Lindau …

ABSTRACT The World Health Organization Classification of Tumors of the Central Nervous
System (WHO CNS5) significantly revised the terminology and diagnostic criteria of …

Abstract Approximately 60% of hemangioblastomas (HBs) have peritumoral cysts adjacent
to the tumor, which can cause neurological deficits due to the mass effect, and the …